A drug or biologic intended for manufacture, importation, sale, distribution, or other regulated activity in the Philippines generally requires prior authorization from the Philippine Food and Drug Administration (FDA). For many drugs and biologics, the relevant authorization is a Certificate of Product Registration (CPR). The CPR confirms that the product has undergone the FDA’s regulatory evaluation under the applicable requirements for quality, safety, and efficacy. The FD